DK3354280T3 - Stabiliserede formuleringer indeholdende anti-interleukin-4-receptor- (IL-4R) antistoffer - Google Patents

Stabiliserede formuleringer indeholdende anti-interleukin-4-receptor- (IL-4R) antistoffer Download PDF

Info

Publication number
DK3354280T3
DK3354280T3 DK18161288.8T DK18161288T DK3354280T3 DK 3354280 T3 DK3354280 T3 DK 3354280T3 DK 18161288 T DK18161288 T DK 18161288T DK 3354280 T3 DK3354280 T3 DK 3354280T3
Authority
DK
Denmark
Prior art keywords
interleukin
antibodies
receptor
formulations containing
containing anti
Prior art date
Application number
DK18161288.8T
Other languages
Danish (da)
English (en)
Inventor
Daniel B Dix
Xiaolin Tang
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Priority claimed from EP11770625.9A external-priority patent/EP2624865B1/en
Application granted granted Critical
Publication of DK3354280T3 publication Critical patent/DK3354280T3/da

Links

DK18161288.8T 2010-10-06 2011-10-05 Stabiliserede formuleringer indeholdende anti-interleukin-4-receptor- (IL-4R) antistoffer DK3354280T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39028310P 2010-10-06 2010-10-06
EP11770625.9A EP2624865B1 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies

Publications (1)

Publication Number Publication Date
DK3354280T3 true DK3354280T3 (da) 2020-09-28

Family

ID=45995014

Family Applications (2)

Application Number Title Priority Date Filing Date
DK18161288.8T DK3354280T3 (da) 2010-10-06 2011-10-05 Stabiliserede formuleringer indeholdende anti-interleukin-4-receptor- (IL-4R) antistoffer
DK11770625.9T DK2624865T3 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK11770625.9T DK2624865T3 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies

Country Status (13)

Country Link
AR (1) AR083338A1 (hr)
DK (2) DK3354280T3 (hr)
ES (2) ES2820246T3 (hr)
HK (1) HK1258305A1 (hr)
HR (1) HRP20181822T1 (hr)
HU (1) HUE052089T2 (hr)
LT (1) LT2624865T (hr)
PT (1) PT3354280T (hr)
RS (1) RS57850B1 (hr)
SI (1) SI2624865T1 (hr)
TW (7) TWI498121B (hr)
UA (1) UA111731C2 (hr)
UY (1) UY33652A (hr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3470432T (pt) 2012-08-21 2021-12-14 Regeneron Pharma Métodos para tratamento ou prevenção da asma por meio de administração de um antagonista de il-4r
HUE046410T2 (hu) * 2013-06-21 2020-03-30 Sanofi Biotechnology Eljárások orrpolipózis kezelésére IL-4R-antagonista beadásával
AU2014284235B2 (en) * 2013-06-21 2019-11-21 Regeneron Pharmaceuticals, Inc. Methods for treating nasal polyposis by administering an IL-4R antagonist
US10066017B2 (en) 2014-11-14 2018-09-04 Sanofi Biotechnology Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist
EP4344706A3 (en) 2017-10-30 2024-05-22 Sanofi Biotechnology Methods for treating or preventing asthma by administering an il-4r antagonist

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608693B2 (en) * 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
ES2332082B1 (es) * 2008-07-24 2010-10-26 Consejo Superior De Investigaciones Cientificas (Csic) 45% Sistema de alineacion de patrones en un sustrato mediante litografia por estencil.
CN102066649B (zh) * 2008-09-10 2013-05-15 日本爱克兰工业株式会社 交联丙烯酸系纤维和其制造方法
TW201039854A (en) * 2009-03-06 2010-11-16 Genentech Inc Antibody formulation

Also Published As

Publication number Publication date
TWI782325B (zh) 2022-11-01
TW201924718A (zh) 2019-07-01
HUE052089T2 (hu) 2021-04-28
UA111731C2 (uk) 2016-06-10
DK2624865T3 (en) 2018-10-22
HK1258305A1 (zh) 2019-11-08
TWI568445B (zh) 2017-02-01
TW201542229A (zh) 2015-11-16
TW201716086A (zh) 2017-05-16
TW202102262A (zh) 2021-01-16
RS57850B1 (sr) 2018-12-31
TWI679988B (zh) 2019-12-21
ES2820246T3 (es) 2021-04-20
LT2624865T (lt) 2018-10-25
TW202320851A (zh) 2023-06-01
TW201221141A (en) 2012-06-01
PT3354280T (pt) 2020-09-01
SI2624865T1 (sl) 2018-10-30
UY33652A (es) 2012-04-30
HRP20181822T1 (hr) 2018-12-28
TWI498121B (zh) 2015-09-01
TW202026011A (zh) 2020-07-16
TWI690329B (zh) 2020-04-11
ES2687813T3 (es) 2018-10-29
AR083338A1 (es) 2013-02-21
TWI718890B (zh) 2021-02-11

Similar Documents

Publication Publication Date Title
IL283424B1 (en) Stabilized formulations that include antibodies against the interleukin receptor (il-4r)
HRP20181821T1 (hr) Stabilizirani pripravci koji sadrže anti-interleukin-6 receptorska (il-6r) antitijela
HRP20170983T1 (hr) Pripravci s visokom koncentracijom antitijela
HK1258305A1 (zh) 含有抗白介素-4受體(il-4r)的抗體的穩定製劑
EP2588141A4 (en) ANTIBODY FORMULATIONS